World
Moderna Partner Brings Production Muscle to Covid Battle
- Lonza has heard from scores of drugmakers looking for scale
- Innovators need manufacturing capacity to supply global need
Lonza Group’s facility in Portsmouth, New Hampshire.
Source: Lonza Group AG
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Drugmakers racing to make Covid-19 vaccines and therapies are seeking out specialized manufacturers like Moderna Inc.’s partner Lonza Group AG that can scale up production to billions of doses needed to supply the world.